Ross Muken

This profile gathers the share dealings of Ross Muken in SOPHiA GENETICS SA, where the filings describe the role as chief executive. Between 19 March 2026 and 5 October 2026, the trades on record add up to 14 filings.

Every open-market trade on record is a sale: 12 sales worth €212k. The rest of the record consists of 2 share grants.

The record was last updated on 7 October 2026 with an open-market sale (€71k) in SOPHiA GENETICS SA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.